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The introduction of clinical Positron Emission Tomography (PET) in oncology in
the 1990s has substantially changed the management of patients with cancer and
become one of the diagnostic modalities with the fastest growth worldwide (Buck et al.,
2010). The major hurdle delaying the proliferation of PET was partly due to its high
initial investment and insufficient third-party reimbursement (Keppler & Conti, 2001).
Hong Kong, a region with about half the economic strength of Germany, was able to
sustain a higher ratio of PET-CT scanners than that of Germany. Through the study of
the PET utilization in Hong Kong, this research is to (i) explore the factors contributing
to this phenomenon; and (ii) find out if those factors are applicable to other developing
countries.
The key factors found contributed to a higher ratio of PET-CT scanners in Hong
Kong were: 1) medical expertise in a regionally profound disease; 2) the direct payment
culture which enables an economically efficient and a cost-effective operation; 3) the
influx of patients from neighboring countries; and 4) the reputation of its medical
services. Applying these factors, citizens in developing countries were able to have
access to the latest and expensive medical technology.
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CHAPTER 1
INTRODUCTION

Cancer is the second leading cause of death in the United States (U.S.), just
behind heart disease, according to the latest data provided by the Centers for Disease
Control and Prevention (CDC, 2009). The risk, in this country, of being diagnosed with
cancer is approximately one in two for men, and one in three for women; the risk of
dying from cancer is approximately one in four for men, and one in five for women
(American Cancer Society, 2010a). Another publication furnished by the American
Cancer Society in 2011, Global Cancer Facts & Figures 2nd Edition, illustrated the
global picture of cancer statistics in 2008 and the near future trend:
Worldwide, one in eight deaths is due to cancer; cancer causes more deaths
than AIDS, tuberculosis, and malaria combined. When countries are grouped
according to economic development, cancer is the leading cause of death in
developed countries and the second leading cause of death in developing
countries (following heart diseases). According to recent World Health
Organization (WHO) projections, cancer will have replaced ischemic heart
disease as the overall leading cause of death worldwide in 2010. (p. 1)
Those statistical results shown above from both the U.S. and the world revealed
that cancer has become a prominent disease in the public health of human history.
Every year, it profoundly affects not only tens of millions of people who are diagnosed
with cancer, but also their families and friends.
Since the signing of the National Cancer Act in 1971 (OGCR), the United States
has devoted a tremendous amount of resources to cancer research and the investment
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is making a difference now. The U.S. cancer death rate began to drop in 1992; the
combined incidence rate of all new cancers has been falling since 1999; and cancer
patients live longer and enjoy a better quality of life than those of the previous
generation. However, the incidence rates of skin cancer, kidney cancer, thyroid cancer,
and liver cancer are rising. As this nation’s population grows and ages, more people
are expected to get cancer during their lifetime (National Cancer Institute, 2010).
In order to treat cancer effectively, early detection is the key. The earlier a
cancer is detected, the better the chances that treatment will work and the better the
survival rate (American Cancer Society, 2010b; National Cancer Institute, 2011b). A
system has been developed to describe the status of a person’s cancer condition. It is
called cancer staging.
Staging describes the severity of a person’s cancer based on the extent of the
original (primary) tumor and whether or not cancer has spread in the body.
Staging is important for several reasons:
•

Staging helps the doctor plan the appropriate treatment.

•

The stage can be used to estimate the person’s prognosis.

•

Knowing the stage is important in identifying clinical trials that may be
suitable for a particular patient.

•

Staging helps health care providers and researchers exchange
information about patients; it also gives them a common terminology for
evaluating the results of clinical trials and comparing the results of
different trials. (National Cancer Institute, 2011a, Cancer Staging, para. 1)
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It is obvious that the staging process is very important because treatment and
outlook for recovery depends on the stage of a cancer. For early cancer, surgery may
be the best option. For more advanced cancer, however, surgery may not be useful.
Other treatment regiments such as chemotherapy or radiation therapy may be more
appropriate (American Cancer Society, 2011b).
Due to its capability of earlier and more precise diagnosis, molecular imaging has
become a popular term of medical diagnosis in recent years (Peterson & Manning,
2009). Positron Emission Tomography (PET), the most common molecular imaging
modality, is very sensitive in the detection of biological abnormalities in neurological
disorders with no CT or MRI anatomic changes, or even before symptoms (Phelps,
2000).
Since the Center for Medicare and Medicaid of the United States started
reimbursement for the clinical PET utilization in oncology in the 1990s, and especially
after the invention of PET-CT in 2000, PET has substantially changed the management
of patients with cancer and become one of the diagnostic modalities with the fastest
growth worldwide (Buck et al., 2010).
Representing one of the largest growth medical modalities in the world,
approximately 2,000 PET-CT scanners were installed in the United States, 70 were
installed in Germany (Buck et al., 2010), and 12 were installed in Hong Kong (J.
Cheung., personal communication, October 27, 2010).
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Table 1
Demographic, Economic, and PET-CT Data in the United States, Germany, and Hong
Kong (2009)

Nation

Population

Number of

Ratio

GDP per

(million)

PET-CT

(per million)

Capita (US$)

United States

307

2,000

6.5

47,240

Germany

82

70

1.2

42,560

Hong Kong

7

12

1.7

23,900

Note. Adapted from Buck et al. (2010), Census & Statistics Department of Hong Kong
SAR (2010a), and World Bank (2010).

Statement of the Problem
As shown in Table 1, Hong Kong supported a higher PET-CT scanner per
population ratio (1.7 vs.1.2) than that of Germany with only 56% of its gross domestic
product (GDP) per capita. In fact, Germany is a member of the G7 nations which are
considered the first tier of economic strength countries in the world. How can Hong
Kong, a region with about half the economic strength of Germany, sustain a higher ratio
of PET-CT scanners than Germany? According to Keppler and Conti (2001), the major
hurdle in utilizing PET is the financial burden associated with the expensive equipment
and running cost. The average cost of setting up a PET center with the
radiopharmaceutical production capacity ranged from US$5 million (low-cost scanner)
to over US$6.2 million (high-end scanner) in the U.S. The running cost ranged from
US$1.6 million to over US$2.6 million per year. If this advanced PET technology can
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be utilized in a way that countries with less economic strength are able to afford, it will
have a tremendous health benefit to their cancer patients. Therefore, the purpose of
this research study is to (i) explore the factors contributing to the PET utilization
development in Hong Kong; and (ii) find out if those factors are applicable to other
developing countries.

Research Questions
This study looked at the history of PET utilization development as well as
investigated the medical and socioeconomic environment in Hong Kong. The following
questions served as structural guiding steps for the direction of this research.
Question 1. What is the clinical advantage of PET and PET-CT in the detection
and monitoring of cancer patients compared to conventional diagnostic imaging
modalities?
Question 2. How has the medical environment in Hong Kong affected PET
utilization development?
Question 3. How has the socioeconomic environment in Hong Kong affected
PET utilization development?

Significance of the Problem
Due to the adoption of western lifestyles in developing countries, such as
smoking, high fat and high cholesterol diet, lack of physical exercise, being overweight,
use of birth control pills, and use of alcohol, cancers related to these risk factors, such
as lung, breast, and colorectal cancers will continue to rise (American Cancer Society,
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2011a). In developing countries, public funding available for the healthcare sector is
not as abundant as funding in economically developed countries (World Health
Organization, 2011). If the experience of PET utilization in Hong Kong can provide
significant insights for a sustainable model of utilizing expansive advanced medical
technology with less financial burden on the society, it will significantly benefit the vast
number of people in those economically developing countries.

Limitations and Delimitations
As the application of PET technology in developing countries only occurred in the
last 10 years, limited prior research is available. This research looked into the financial
aspect of the currently functioning medical facilities, both in the public and private
sectors of Hong Kong. The willingness of those medical facilities to provide business
information was a limitation. Therefore, information came from information-rich
persons who have witnessed and also participated in the entire development cycle of
PET utilization in Hong Kong for the last 10 years. The point of view of these finite
experts contributed to the limited scope of this study. Also, manpower, financial, and
time resources were limitations for this study as well.
Many of the examples and literature presented in the following sections focus on
cancer and molecular imaging, primarily because that is the area in which the author is
profoundly involved.
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Definition of Terms
Clinical advantage of PET: The clinical advantage of PET expresses in terms of
its higher diagnostic sensitivity and specificity compared with conventional diagnostic
imaging modalities, which include the diagnosis, staging, monitoring treatment, and
detecting recurrence of a variety of tumors (Alavi & Reivich, 2002).
Computed Tomography (CT): Computed Tomography is a diagnostic imaging
procedure that uses X-rays to produce 2-dimensional and 3-dimensional cross-sectional
images or "slices" of areas of the body. Characteristics of the internal structure of an
object such as dimensions, shape, internal defects, and density can be found from CT
images (Computed tomography, 2011).
Conventional diagnostic imaging: Conventional diagnostic imaging is a general
term referring to the imaging methods of computed tomography (CT), magnetic
resonance imaging (MRI), sonography (US), and Radiography (X-ray) (Adams, Baum,
Stuckensen, Bitter, & Hör, 1998).
Developing countries: The economy of countries are divided according to 2010
gross national income (GNI) per capita using the World Bank Atlas method: low income,
$1,005 or less; lower middle income, $1,006 - $3,975; upper middle income, $3,976 $12,275; and high income, $12,276 or more. The World Bank classifies all low- and
middle-income countries as developing economies. However, the use of this term is
convenient. The levels of development may vary widely within so-called developing
countries (World Bank, 2012).
Diagnostic sensitivity: The conditional probability that a person having a disease
will be correctly identified by a clinical test, i.e., the number of true positive results
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divided by the total number with the disease (which is the sum of the numbers of true
positive plus false negative results) (Mosby's Medical Dictionary, 2009a).
Diagnostic specificity: The conditional probability that a person not having a
disease will be correctly identified by a clinical test, i.e., the number of true negative
results divided by the total number of those without the disease (which is the sum of the
numbers of true negative plus false positive results) (Mosby's Medical Dictionary,
2009b).
Magnetic Resonance Imaging (MRI): Magnetic Resonance Imaging is an
advanced imaging method using a magnetic field, radio waves and a computer system
to produce 3-D cross-sectional images of organs and internal structures in the body.
Because the signal detected by an MRI machine varies depending on the water content
and local magnetic properties of a particular area of the body, different tissues or
substances can be distinguished from one another in the study image. For example,
an MRI exam of a joint can provide detailed images of ligaments and cartilage, which
are not visible using other study types. In some cases, a magnetically active material
(called a contrast agent) is used to show internal structures or abnormalities more
clearly (Magnetic Resonance Imaging, 2011).
Metastasis: By moving through the bloodstream or lymphatic system, cancer
cells can spread from the primary site to lymph nodes or to other organs, where they
may form new tumors. The spread of cancer is called metastasis (National Cancer
Institute, 2011a).
Ultrasound (sonography): Ultrasound imaging uses high-frequency sound waves
to produce pictures of the inside of the body. Because ultrasound images are captured
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in real-time, they can show movement of the body's internal organs as well as blood
flowing through blood vessels. Ultrasound exams do not use ionizing radiation as used
in x-rays (Medical Imaging, 2011).
X-ray (Radiography): Radiography can be thought of as “X-ray photography”. It
is the visualization of the internal parts of the body (object) by passing an X-ray beam
through some section of a patient’s body to form a static image. The images that are
formed are recorded either on film or some form of digital media (Medical X-ray, 2011).
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CHAPTER 2
REVIEW OF LITERATURE

Molecular Imaging
The Society of Nuclear Medicine has adopted an official definition for molecular
imaging: “Molecular imaging is the visualization, characterization, and measurement of
biological processes at the molecular or cellular levels in humans and other living
systems” (Mankoff, 2007, p. 18N).
Conventional diagnostic imaging modalities, such as Computed Tomography
(CT), Magnetic Resonance Imaging (MRI), X
X-ray, and ultrasound, show the pathologies
through the visualization of the
e presence, location
location, and extent. PET as the most
common molecular imaging modality
modality, in the contrary, can detect pathological changes
at the molecular or cellular level before anatomical changes of the tissues (Peterson et
al., 2009).

X-ray

CT

MRI

PET

Figure 1. Anatomy vs Function
Function: X-ray,
ray, CT, and MRI are anatomical imaging. PET is
functional (physiological) imaging.

11
As shown in Figure 1, conventional diagnostic imaging (X-ray, CT, MRI, etc.)
looks through the anatomy (structure) of the body to examine if there is any pathological
abnormality (disease). In contrast, only abnormal functionality (physiology) of the body
will show up as a distinct visualization — “hot” spot (increased uptake) on a PET scan
image (as pointed by the arrow in Figure 1). The rest of the normal tissues and organs
will show as a light and faint background. This distinct feature of visualization of
functional abnormality in the cellular and molecular level enables molecular imaging to
detect hidden cancers in an early stage before any signs of anatomical change (Mankoff,
2007; Peterson et al., 2009).
PET whole body imaging in cancer provides the means to (i) identify early
disease, (ii) differentiate benign from malignant lesions, (iii) examine all organs
for metastases, and (iv) determine therapeutic effectiveness. Diagnostic
accuracy of PET is 8-43% higher than conventional procedures and changes
treatment in 20-40% of the patients … in lung and colorectal cancers, melanoma,
and lymphoma, with similar findings in breast, ovarian, head and neck, and renal
cancers. (Phelps, 2000, p. 9226)

Principle of 18F-FDG PET
Today, the most commonly used PET tracer for clinical molecular imaging in
oncology is 18F-FDG.

18

F-FDG is an analog of glucose labeled with a radioactive

positron emitter. The definition of cancer, in liberal terms, is rapid cell growth and
replication without control. Therefore, cancer cells’ metabolic rate is two to 10 times
more than that of normal cells. “18F-FDG PET exploits the typically increased glucose
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metabolism of tumor tissues, compared with surrounding normal tissues” (Peterson et
al., 2009, p. 156).
In a typical 18F-FDG PET examination, the radioactive 18F-FDG is injected
intravenously. Through a PET scanner, the radioactive signals emitted by 18F-FDG are
transformed into a three-dimensional image of a human body, and those cancer tissues
are lit up as hot spots for visualization.

This is the principle behind an 18F-FDG PET

(Peterson et al., 2009; Phelps, 2000).

Figure 2. PET images of colorectal cancer.

As illustrated in Figure 2, the radioactive sugar (glucose) injected into the body
was absorbed by the cancer cells in a much higher ratio. They showed up as hot spots
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(a very large and intensive primary tumor in the rectum, and multiple liver metastases)
on a three-dimensional PET image compared to surrounding normal tissues, making
them the easy targets for disease identification.

The Development of PET-CT
PET-CT, which captured the award of “Time Magazine's Medical Invention of the
Year 2000” (Jaroff, 2000), is a technological breakthrough which integrates two
separate diagnostic modalities, anatomical imaging (CT), and molecular and
physiological imaging (PET), into one device and procedure. This combination results
in high-resolution anatomical images accurately fused with functional data and the
further increase of sensitivity and specificity of cancer imaging (Townsend, 2008). The
imaging time per patient is reduced by 60% as well (Sitt & Ho, 2002). Using today’s
most advanced model, Biograph m-CT, a whole body PET-CT scan can be done in five
minutes, a 90% reduction in imaging time compared to the first generation of dedicated
PET scanner (Siemens, 2010).
In Figure 3, the top row is PET images; the middle row is PET-CT fusion images;
and the bottom row is CT images. Those bright spots on the top row of the PET
images showed the multiple and extensive metastases of cancer cells in both lungs,
which provide the diagnosis of the patient. However, the locations of those diseased
lymph nodes were not precise because there was no distinct anatomical reference
(Townsend, 2008). The bottom row of CT images demonstrated a clear anatomical
structure of the lung, which serves as a road map of the human body.

Combining the

top row of PET images and the bottom row of CT images, the middle row of the PET-CT
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fusion image not only provided the patient’s diagnosis but also the exact location of
those metastatic lymph nodes.

PET Image 

PET-CT Fusion Image 

CT Image 

Figure 3. Illustration of PET-CT fusion images.

Figure 3 illustrates how the functional data (PET) and the anatomical data (CT) of
two imaging modalities combined together increase the sensitivity and specificity of
cancer imaging.
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Diagnostic Effectiveness of PET and PET-CT in Oncology
18

F-FDG PET allows the detection of malignant tumors based on increased

glucose uptake (metabolism). In a typical PET imaging, the scan range will cover from
the base of the skull down to the middle of the thigh. Basically, most of the internal
organs will be covered by a single image to determine if the patient has concealed
cancer. As cancer cells are generally highly metabolically active and divide rapidly,
they consume two to 10 times more glucose than normal cells (Peterson et al., 2009).
Therefore, they appear as “hot spots” in the PET scan, which make them the easy
target for tumor identification.
As an example, approximately 40% of the diagnosed solitary pulmonary lung
nodule cases are malignant (Bury et al., 1996). PET scan has the ability to distinguish
between malignant and benign nodules with a 90%+ accuracy. According to Buck et
al., “18F-FDG PET has a sensitivity of 89%-100%, a specificity of 69%-100%, and an
accuracy of 89%-96%” (2010, p. 8).

Evaluation of Response to Treatment
According to the standard Response Evaluation Criteria in Solid Tumors used by
the World Health Organization (WHO, 2007), the response to treatment is measured
and estimated by the volume reduction of the tumor. However, there is a time lag of
between three to 12 months from the time of the tumor responding to therapy to the
reduction of the tumor volume (Buck et al., 2010). In contrast, PET measures the
glucose metabolism as an indicator of effective therapy because cancer that is
successfully treated will no longer be metabolically active (Buck et al., 2010).

16
Therefore, PET scan can show the effectiveness, at a much earlier time, of surgery,
chemotherapy, and radiotherapy in the treatment of cancer.
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F-FDG PET-CT to Aid in the Planning of Radiotherapy

The planning of radiotherapy has traditionally relied heavily on CT using the
Response Evaluation Criteria in Solid Tumors, which measures the physical volume of
the target volume. The use of metabolic information from PET leads to the
measurement of biologic target volume, which can alter the radiation field by increasing
or reducing the target volume. Increasingly, 18F-FDG PET-CT is being incorporated
into the treatment-planning process and promises to improve the ability to confidently
identify regions of disease (Ford, Herman, Yorke, & Wahl, 2009).
For example, a positive response from previous treatment may show a shrinking
biologic target volume on PET images compared to the same physical tumor size on CT
images. Consequently, by applying the PET data, the radiation field can be reduced
and the radiation dose to neighboring tissues can be minimized as well.
As mentioned by Buck et al., “overall survival of patients receiving PET-based
radiation treatment planning was significantly higher than that of patients treated without
the use of PET” (2010, p. 10). The role of 18F-FDG PET is expected to continue to
evolve and provide additional benefits to radiation oncology.

Difficulties of 18F-FDG PET for Liver Cancer
Liver cancer is one of the top three causes of cancer death in many Asian
countries, including Hong Kong, Taiwan, Singapore, and Japan (Ho, Chen, Yeung, &

17
Cheng, 2007). Although 18F-FDG is very sensitive in the detection of many cancers, it
is known that 18F-FDG PET has a 40-50% false negative rate in the detection of liver
cancer (Chen, Ho, & Feng, 2004; Ho, Yu, & Yeung, 2003).
Unlike Asian countries, liver cancer is a rare disease in the United States.
However, an upward trend of the disease has been shown recently because of the
increasing frequency of hepatitis C viral infection and the influx of Asian immigrants (Ho
et al., 2003). Accurate PET imaging protocol for liver cancers did not exist at the time
when PET was first introduced into Hong Kong by the Hong Kong Sanatorium &
Hospital (HKSH) in 1999 (Chen, Ho, & Feng, 2004; Ho, Yu, & Yeung, 2003). In order
to resolve this issue, practitioners and research scientists at HKSH explored the
utilization of other PET tracers and previously published research in the detection of
liver cancer. Details of how to solve this issue of liver cancer detection with PET will be
elaborated on more in chapter 4 of this paper.

PET Utilization in Alzheimer’s Disease
PET application has gone beyond oncology. One of the major fields of research
utilizing PET technology is in Alzheimer’s disease. Due to the aging population, more
and more people are potentially affected by this disease (Alzheimer’s, 2010).
By 2030, 20% of all Americans, about 70 million people, will pass their 65th
birthday (Cavanaugh, & Cavanaugh, 2010, back cover). “Life expectancy rose from 49
years in 1900 to 68.1 years in 1950 and then 77.8 years in 2004, a gain of almost 30
years in just over a century in the United States” (Himes & Meyer, 2010, p. 2).
Alzheimer’s disease (AD), the most common cause of dementia, will affect more and
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more people. In fact, it is estimated that as many as 5.2 million people in the United
States have AD (National Institute on Aging, 2010a). This number is expected to grow
over the next 50 years as the population ages and life span increases (National Institute
on Aging, 2010b).
In Australia, the number of people affected by dementia is expected to triple from
the current 257,300 (1% population) in 2010 to 1,130,700 (2.8% of the projected
total population) by 2050…. AD currently costs the Australian health system
A$3.2 billion a year in direct costs, and is expected to be A$6 billion within 5
years. If interventions were able to delay the onset of the disease by even 5
months, there would be a 5% reduction in the cost of AD to the Australian
economy; if we could delay onset by 5 years, we would halve the costs [2]. (Ellis
et al., 2010, p. 291)
In Hong Kong, the 65 and over age group rose from 12% in 2006 to 12.9% in
2009 (Census & Statistics Department, 2010b). The number of people affected by AD
is consistent with the increase in life expectancy and population aging of the worldwide
trend. AD affects all walks of lives. An outstanding scholar of Hong Kong and the 2009
Nobel Prize winner in Physics, Dr. Charles K. Kao, is unfortunately afflicted by this
disease and could not personally receive his honor in Norway.
It is a worldwide effort to address this AD issue from all fronts. Through
research, more is being learned about how Alzheimer's affects the brain. The
Australian Imaging Biomarkers and Lifestyle (AIBL) Flagship Study of Aging, utilizing
the Pittsburgh compound B (11C-PiB) PET and MRI, has completed its first 18-month
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follow-up project in collaboration with the Alzheimer’s Disease Neuroimaging Initiative
(ADNI) worldwide effort (Ellis et al., 2010).

Training Needs for Physicians Entering PET Modality
Experienced and competent physicians who can provide PET-CT analysis
service are in great demand considering the rapid expansion of PET modality. Alavi and
Reivich stated,
Training in diagnostic radiology and conventional nuclear medicine is inadequate
for the interpretation of these complex PET studies. It is becoming quite clear
that acquiring optimal skills to interpret FDG-PET images will require at least 6
months of full-time training in this discipline. Fellowships for a period of 1 to 2
weeks as a certificate of competence are unjustifiable and in fact will be a
disservice to the medical community. (2002, p. 2)
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CHAPTER 3
METHODS AND PROCEDURES

Introduction
The purpose of this research study is to (i) explore the factors contributing to the
PET utilization development in Hong Kong; and (ii) find out if those factors are
applicable to other developing countries.
The research questions used as the key concern of the study were:
Question 1. What is the clinical advantage of PET and PET-CT in the detection and
monitoring of cancer patients compared to conventional diagnostic imaging modalities?
Question 2. How has the medical environment in Hong Kong affected PET utilization
development?
Question 3. How has the socioeconomic environment in Hong Kong affected PET
utilization development?

Research Design
The goal of this research was to explore and understand the current practice of
PET imaging modality in Hong Kong, and to evaluate if these factors are applicable to
other developing countries. This type of study is characterized as exploratory and
explanatory. It is, according to McMillan and Schumacher (2010), “To identify
relationships influencing the phenomena” (p. 324). To achieve this objective, the
researcher utilized a qualitative approach based mainly on direct observation of the
common practice related to this field complemented with quantitative data analysis.

21
A study with an emergent design was conducted to examine and understand
what factors were contributing to this phenomenon. Three major approaches were
utilized in this qualitative research: Ethnography—in-depth description and
interpretation of cultural patterns and meanings within a specified culture or social
group; Case Study—in-depth analysis of single entity; and Phenomenology Study—
description and interpretation of the experiences of participants regarding particular
events in order to understand the meaning ascribed to those events (McMillan &
Schumacher, 2010).
To begin explaining this complex phenomenon, the researcher collected data
from the medical and socioeconomic environment in Hong Kong. Secondly, the author
used purposeful sampling including individuals, groups, documents, reports, and sites to
retrieve information-rich cases for an in-depth study. It should be noted that the
researcher is himself one of the pioneers of the PET imaging modality practice who
introduced this new technology to Hong Kong. Per communications with research
institution’s representative, IRB approval was not required for this study (R. Sinha.,
personal communication, November 30, 2011).

Sampling Strategy
The purpose of the sampling strategy was to search for information-rich key
informants, events, or sites to study. The sampling strategy included convenient
sampling and sampling by case type. The sampling by case type consisted of an
extreme case and a typical case. A leader of PET medical imaging modality in Hong
Kong was chosen as the extreme case. One typical case from a private health sector
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was selected to reflect the practical situation. Due to the reluctance of releasing
sensitive operational data, only one private PET center other than the leading PET
center was willing to release operational data on conditions of anonymity.

Research Methodology and Data Collection
First, a quantitative approach was utilized in answering research question #1
about the clinical advantage of PET and PET-CT in the detection and monitoring of
cancer patients, because quantitative data were obtainable and available for this issue.
For research questions #2 and #3, three aspects of the qualitative approach were
utilized in this research; in-depth description and interpretation of cultural patterns; indepth analysis of a single entity; and description and interpretation of the experiences of
participants regarding particular events. Due to the small amount of written information
about the PET cost data survey, circuitous and indirect supporting data were utilized to
illustrate the factors influencing the proliferation of PET in Hong Kong. In order to
estimate the socioeconomic impact on PET development, a cost structure analysis with
a breakdown of the operational budget of PET facility was assessed. Details of the
assumptions and estimates for this cost analysis are given in Chapter 4.
As the application of PET technology in developing countries only occurred in the
last 10 years, limited prior research is available for correlations. The investigator
collected information directly from the source, i.e. directly observed and interacted with
the settings, participants, and documents studied. All of those activities essentially
formed the data collection instrument. As the researcher was an active PET
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practitioner, his active experience with the PET development in Hong Kong was the
backbone of this research.

Inductive Data Analysis
All data collected was synthesized inductively to generate findings. Through
inductive reasoning, these seemingly unconnected and perhaps too extensive findings
generated conclusions to answer the research questions, and ultimately, provided a
new prospective to the statement of the problem. This analysis was developed using a
bottom up approach according to the detailed particulars. It opened up a new way of
understanding PET utilization in a developing region, as contrasted with the medical
environment of developed nations such as Germany and the U.S.
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CHAPTER 4
FINDINGS AND DATA ANALYSIS

Introduction
The purpose of this research study is to (i) explore the factors contributing to the
PET utilization development in Hong Kong; and (ii) find out if those factors are
applicable to other developing countries.
The research questions used as the key concern of the study were:
Question 1. What is the clinical advantage of PET and PET-CT in the detection and
monitoring of cancer patients compared to conventional diagnostic imaging modalities?
Question 2. How has the medical environment in Hong Kong affected PET utilization
development?
Question 3. How has the socioeconomic environment in Hong Kong affected PET
utilization development?

Research Question Results
Research Question 1
What is the clinical advantage of PET and PET-CT in the detection and
monitoring of cancer patients compared to conventional diagnostic imaging modalities?
Referring to the principle of PET modality illustrated in Chapter 2, PET imaging
distinguishes changes in cancer cells at the cellular level by detecting differences in
their metabolic activity compared with normal cells. This contrasts with conventional
diagnostic modalities such as CT, MRI, ultrasound, and X-ray, which detect structural
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change. The research study of Jadvar, Alavi and Gambhir (2009) indicated the clinical
diagnostic advantage of 18F-FDG PET for lung, breast, and colon cancers.
Table 2 is a summary of 39 meta-analysis results by Gould et al. (2003)
comparing the diagnostic accuracy of CT and 18F-FDG PET for mediastinal staging in
patients with non-small cell lung cancer, and it demonstrated that PET was more
accurate than CT.

Table 2
PET and CT for Mediastinal Staging in Lung Cancer
Variable

Median Sensitivity (IQR)

Median Specificity (IQR)

CT
(1119 patients in
23 studies)

61 (50-71)

79 (66-89)

(1959 patients in
32 studies)

85 (67-91)

90 (82-96)

PET

Note: IQR = interquartile range
Source: Gould, M. K., Kuschner, W. G., Rydzak, C. E., Maclean, C. C., Demas, A.
N., …Owens, D. K. (2003). Test performance of positron emission tomography and
computed tomography for mediastinal staging in patients with non-small cell lung cancer.
Annals of Internal Medicine, 139, 879-892.

As approximately 40% of solitary pulmonary lung nodule cases are malignant
(Bury et al., 1996), 18F-FDG PET has the ability to distinguish between malignant and
benign nodules with “a sensitivity of 89%-100%, a specificity of 69%-100%, and an
accuracy of 89%-96%”, as stated by Buck et al. (2010, p. 8).
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Table 3
Sensitivity and Specificity of PET and CDI in Detection of Colorectal Cancer Recurrence
Year

Sensitivity

Sensitivity

Specificity

Specificity

(CDI)

(PET)

(CDI)

(PET)

Beets et al.24

1994

8/15 (53)

14/15 (93)

18/20 (90)

19/20 (95)

Schiepers et al.35

1995

30/47 (65)

45/47 (96)

25/25(72)

34/35 (97)

Keogan et al.36

1997

11/13 (84)

12/13 (92)

2/5 (40)

5/5 (100)

Ogunbiyi et al.37

1997

-

19/21 (90)

-

26/26 (100)

Valk et al.28

1999

21/31 (68)

30/31 (97)

76/84 (90)

81/84 (96)

Flamen et al.38

1999

24/33 (73)

31/33 (94)

62/70 (89)

69/70 (99)

Whiteford et al.31

2000

22/31 (71)

28/31 (90)

33/39 (85)

35/39 (92)

Staib et al. 30

2000

-

22/23 (96)

-

74/77 (96)

Lonneux et al.34

2002

11/15 (73)

15/15 (100)

61/63 (96)

62/63 (98)

CDI = conventional diagnostic imaging. PET = Positron Emission Tomography
Data are numbers with percentages in parentheses.
Source: Watson, A. J., Lolohea, S., Robertson, G. M., & Frizelle, F. A. (2006). The role
of positron emission tomography in the management of recurrent colorectal cancer: A
review. Diseases of the Colon & Rectum, 50, 102-114. doi: 10.1007/s10350-006-0735-7

Table 3 is a statistical summary of a literature research study by Watson,
Lolohea, Robertson, and Frizelle (2006) that reviewed the role of PET in the
assessment of patients with suspected recurrent colorectal cancer. The result of this
study, covering patient data from 1994 to 2002, further confirmed PET is more sensitive
and more specific than conventional diagnostic imaging for metastatic disease and local
recurrence of colorectal cancer respectively.
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Conclusion. As stated by Phelps (2000), one of the PET inventors, “Diagnostic
accuracy of PET is 8-43% higher than conventional procedures and changes treatment
in 20-40% of the patients … in lung and colorectal cancers, melanoma, and lymphoma,
with similar findings in breast, ovarian, head and neck, and renal cancers” (p. 9226).
The emergence of PET-CT hybrid scanners resulted in high-resolution
anatomical images accurately fused with functional data, and this new technology
further increased the sensitivity and specificity of cancer imaging with PET modality
(Townsend, 2008).

Research Question 2
How has the medical environment in Hong Kong affected PET utilization
development?
According to the latest information confirmed by Mok of the Radiation Board
(division of the Department of Health and a radiation governing body in Hong Kong,
Appendix A), there were a total of 12 PET-CT scanners in Hong Kong in 2011. Four
were at public hospitals (three were operational and one was under installation), and the
other eight were in the private sector. The private sector actually leads the clinical PET
development in Hong Kong. According to the information of establishment date
provided by the Radiation Board (Appendix A), the first, second, and the third PET
scanners were set up by three private entities in 1998, 2001, and 2002 respectively.
Four years after the introduction of PET technology to Hong Kong, the first public PET
facility was finally launched into service in Queen Elizabeth Hospital in 2003. Since the
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first PET scanner became operational in 1999, there have been two private PET centers
were shut down.
Nevertheless, the private sector still has a dominant capacity of a two to one ratio
compared with the public sector today. Looking back at the introduction of PET
technology, it went through numerous roadblocks to gain the confidence and
acceptance of medical professionals as well as cancer patients (HKSH, 2009). One of
the major hurdles was related to a locally profound cancer type – liver cancer which was
difficult to diagnosis using 18F-FDG PET alone (Chen, Ho, & Feng, 2004; Ho, Yu, &
Yeung, 2003).
Through an in-depth case study analysis of liver cancer, a unique clinical PET
expertise was established by the leader of a PET facility in Hong Kong (Ho et al., 2007).
Difficulties of 18F-FDG PET for liver cancer. Liver cancer is one of the top
three causes of cancer death in many Asian countries, including China, Taiwan,
Singapore, and Japan (Ho et al., 2007). Although 18F-FDG is very sensitive in the
detection of many cancers, it is known that 18F-FDG PET has a 40-50% false negative
rate in the detection of liver cancer (Chen et al., 2004; Ho et al., 2003).
Unlike in Asian countries, liver cancer is a rare disease in the United States.
There has only been an upward trend of the disease recently because of the increasing
frequency of the hepatitis C viral infection and the influx of Asian immigrants (Ho et al.,
2003). Accurate PET imaging protocol for liver cancers did not exist at the time when
PET was first introduced into Hong Kong by the Hong Kong Sanatorium & Hospital
(HKSH) in 1999 (HKSH, 2009). In order to resolve this issue, practitioners and
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research scientists at HKSH explored the utilization of other PET tracers and previously
published research in the detection of liver cancer.

Figure 4. The well-differentiated HCCs accumulate 11C-Acetate without 18F-FDG
uptake.

From 2000 to 2002, through a series of tracer kinetic modeling, dynamic
analysis, and numerous trials of imaging protocols, a significantly sensitive and specific
protocol of

11

C-Acetate PET was established in complementing the deficiency of 18F-

FDG in PET imaging of liver masses (Chen, Ho, & Feng, 2003; Chen et al., 2004; Chen,
Ho, & Feng, 2006; Ho et al., 2003).
Ho et al. (2007) further explored and found that the pattern of tracer uptake by
the tumors was correlated with tumor cellular differentiation. The study showed the
well-differentiated liver cancer tumors preferentially accumulated 11C-Acetate (illustrated
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in Figure. 4), whereas the poorly differentiated tumors tended to accumulate 18F-FDG
(illustrated in Figure. 5).

Figure 5. The poorly differentiated HCC tumors tended to be prone to accumulate 18FFDG without 11C-Acetate accumulation.

The research result and the dual-tracer imaging protocol of 11C-Acetate and 18FFDG PET published by Ho et al. (2007) were well-received and recognized by the
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molecular imaging community. It was presented as the cover article for the 2007 issue
of the Journal of Nuclear Medicine—the leading medical journal in the field of nuclear
medicine and molecular imaging. Today, liver cancer is no longer a blank space within
the spectrum of PET diagnosis.
Collaborated PET service. As previously mentioned, liver cancer is one of the
top three causes of cancer death in many Asian countries. According to the clinical
data of The Department of Surgery at The University of Hong Kong (HKU) (2010), tumor
resection and transplant are the most effective cures for this disease. For patients with
unresectable tumors, the advent of radiofrequency ablation and transarterial oily
chemoembolization offers an effective treatment alternative. The Department of
Surgery at HKU is the largest liver cancer referral center in the region. Its liver
transplant service developed into the largest program in China and Southeast Asia, and
it is renowned internationally for its excellence in clinical service and research. By the
end of October 2008, a total of 659 liver transplants had been performed with one-year,
three-year, and five-year survival rates of 92%, 87%, and 84% respectively, and the
mortality rate of hepatic resection for liver cancer was approaching 0% (Department of
Surgery, 2010).
Liver cancer patients from around the world go to Hong Kong to seek treatment
because of its specialty in dealing with this disease. Through collaborations with HKU
and other liver cancer oncologists, HKSH (2009) fully utilized the dual-tracer PET
protocols in the aid of diagnosis as well as therapeutic response monitoring of these
patients. Due to the strong demand, patients may need to wait between a few days to
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one week to schedule their exams, as HKSH is the only center providing 11C-Acetate
and 18F-FDG dual tracer PET-CT service.

Research Question 3
How has the socioeconomic environment in Hong Kong affected PET utilization
development?
Due to the confidentiality concern of their operating costs, only two of the PET
centers in Hong Kong were willing to provide their service volume figures and an
estimate of patient demographic data. The rest of the groups were reluctant and did
not respond to the request from this study. In order to provide an approximation of the
cost of a PET facility, a simplified breakdown of the operational budget analysis was
constructed along with a breakeven throughput estimate.
The major cost components of a PET facility were narrowed down to its PET-CT
scanner, the real estate to house the facility, salaries and benefits associated with the
clinical staff, medical supplies, utilities, and administrative costs to simplify this cost
analysis.

According to the study of Keppler and Conti, the breakeven throughput for a

high-end PET scanner was in the range of 6.75 procedures per day based on the
financial data collected from PET centers in the U.S. (2001). As all the existing
facilities in Hong Kong were equipped with PET-CT scanners (Radiation Board,
appendix B) which are considered high-end PET scanners (Keppler & Conti, 2001), this
breakeven point estimate would be a good reference when applying this cost analysis.
The first item on the cost list is the PET-CT scanner. As those scanners are
mainly manufactured either by Siemens (with manufacturing plants both in the U.S. and
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Germany) and General Electric (with manufacturing plants mainly in the U.S.), these
would be an additional overseas premium and a higher freight charge when these
scanners were purchased by the medical centers in Hong Kong. Therefore, the endusers in Hong Kong would be required to pay a higher cost than their counterparts in
the U.S. or Germany. That translated into a higher upfront setup cost of the medical
equipment in Hong Kong.

Table 4
Global Office Occupancy Costs
Market
(Ranked in December 2010)
1. Hong Kong

Class A/Prime Space
(US$ per square foot)
191.97

2. London – West End

133.02

14. New York, NY – Midtown Manhattan

65.04

24. Washington, DC

53.59

29. Frankfurt

50.21

Note: Adopted from Colliers International (2011), Global office real estate review.

The second expansive item on the list is the real estate housing the PET facility.
According to a recent property survey, illustrated in Table 4, by Colliers (2011), Hong
Kong was ranked the number one city with the highest occupancy cost in the world
(US$191.97/square foot). New York City (Midtown Manhattan), the highest ranking city
from the U.S., came in #14 (US$65.04/square foot). The second highest ranking city
from the U.S. was Washington, DC (US$53.59/square foot), which was rated as #24.
The highest ranking city from Germany was Frankfurt, which was rated as a distant #29
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(US$50.21/square foot). Overall, the cost of space in Hong Kong was three times
more expensive than that in the U.S. and Germany.
The third item on the cost list is the cost of professional staff. A salary survey
conducted by the Nuclear Medicine Technology Certification Board in 2006 identified
the salary range for a PET technologist in the U.S. was from US$40,000 to US$97,700,
with a median value of US$62,868 (2007). Compared to data retrieved from the
Master Pay Scale of the Civil Service Bureau in Hong Kong (2011), the salary level of
the same technologist position was from US$46,151 to US$92,608. These two sets of
data from the U.S. and Hong Kong respectively, therefore, indicated a comparable
salary range for the PET clinical staff from these two regions of the world.
An assumption was made that the PET clinical staff cost in Germany would fall
into a similar range of the U.S. because the GDP per capita of these two countries were
similar (World Bank, 2010).
The last few items for comparison were medical supplies, utility cost, and
administrative cost. Although the PET facilities in Hong Kong needed to import all their
medical supplies from abroad, and hence might incur higher costs than its counterparts
in the U.S. and Germany, the researcher made a simplified assumption and assumed
those costs would fall into a similar range within those regions.
Using the financial data derived from the U.S. and Germany as an average
standard, the costs of setting up and operating a PET facility in Hong Kong was
compared against those standards to arrive at a qualitative comparison. Table 5 is the
consolidation summary of the data listed in the previous paragraphs.
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Table 5
A Simplified Cost Analysis of PET-CT Facility
U.S.

Germany

Hong Kong

Cost of PET-CT Scanner

average

average

higher

Cost of Space

average

average

3 x higher

Cost of Professional Staff

average

average

average

Other Costs (medical supplies,
utilities, and administrative
cost)

average

average

average

According to Keppler and Conti (2001), the scanner and space costs were the
dominant capital expenditures, making up over 80% of total costs of a PET facility. For
this reason, it is clear to conclude from Table 5 that the total cost of setting up and
operating a PET center in Hong Kong would be much higher than for its counterparts in
the U.S. and Germany. As the breakeven point for a high-end PET scanner was in the
range of 6.75 procedures per day based on the financial data in the U.S. (Keppler et al.,
2001), PET centers in Hong Kong would require a procedure number higher than the
6.75 in order to breakeven. However, the majority of PET centers in Hong Kong
performed six to eight procedures a day (Anonymous, personal communication,
October 29, 2010), which would probably fall short of the breakeven point based on the
financial viability calculation from Keppler et al. (2009).
Excluding the extreme case of a PET center leader in Hong Kong, which
performed scanning on 25 to 27 patients a day on its two PET scanners (M. Yeung.,
personal communication, October 27, 2010), the majority of the PET centers in Hong
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Kong have been operational for more than three years. If a PET facility was not able to
produce positive net income in more than three years, its operation would probably not
be sustainable. According to information confirmed by the Radiation Board (Appendix
A), two private PET centers were closed in the last few years in Hong Kong. These
two centers did not last more than two years (J. Cheung., personal communication,
October 27, 2010; October 9, 2011). Therefore, the researcher would make an
assumption that the existing PET centers with more than three years of operational
history were financially viable.
If this viable operation assumption of the researcher is valid for the majority of
PET centers in Hong Kong, how can those centers sustain a financially viable operation
with a substantially higher capital expenditure and a lower procedure number per day
than the breakeven point?
In order to answer this question, an approach of in-depth description and
interpretation of cultural patterns, an ethnography, was utilized to explore the possible
answers.
Direct payment culture. According to the information from Buck et al. (2010),
the costs of PET examination ranged between approximately $885 and $1,474 in
Germany, and $1,030 to $2,109 in the United Kingdom. According to two research
studies completed in the early 2000s, the cost of PET examination in the US ranged
approximately from $1,600 to $2,986 (Berger, Gould, & Barnett 2003; Keppler & Conti,
2001). In Hong Kong, the cost range was approximately between $900 and $2,179 (M.
Yeung., personal communication, October 26, 2010). Based on the data shown in
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these research studies, the cost of obtaining a PET scan was in a similar range among
European countries, the U.S., and Hong Kong.
Hong Kong is considered to be a direct payment culture as compared to its
counterparts of the US and Europe. The cost of a PET examination is paid out directly
from a patient’s own pocket in most of the cases in Hong Kong. In contrast, costs of
PET examination in the US and Europe are reimbursed by insurance companies,
Medicare, or other social medicine systems (Benjamin, 1999; Biersack, 2009). In Hong
Kong, the common payment methods for medical providers are cash, credit cards such
as Visa and MasterCard, and checks, as shown on the lists of medical providers from
the local US Consulate (US Consulate Hong Kong, 2011). For patients who have
medical insurance coverage, the common practice is that patients will settle the medical
bills with their medical providers first, and then the insurance companies will reimburse
the medical costs to their clients after the insurance claims are approved. That is
equivalent to 100% reimbursement of the medical system in the United States, which is
an incomprehensible level.
Benjamin (1999) stated that numerous HMOs have made a hasty withdrawal
from the Medicare market, citing increased costs and inadequate federal
reimbursement. Biersack (2009) pointed out that the PET-CT utilization development
was hampered by the reimbursement issues in Germany as well.
Appendix B holds a collection of the medical claim forms used by major
insurance companies in Hong Kong. One of the distinct requirements on all of these
forms is to furnish medical or hospital payment receipts showing the charges for the
treatment received. This is another evidence of the direct payment culture.
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As the imaging charge is settled between patients and the facility at the same
time that the PET service is performed, the most important issues of manpower savings
were outlined in the following list:
1. Sending bills to insurance providers or reimbursement agencies
2. Keeping track of the correct reimbursement amount and following up on any
overdue payment
3. Updating the service billing coding
4. Fulfilling the ongoing updates of regulatory requirements such as the Centers
for Medicare and Medicaid Services in order to be eligible for reimbursement
The removal of the entire insurance reimbursement department, which is a
common division within any medical institution in the U.S. and in Germany (Benjamin,
1999; Biersack, 2009), provides tremendous savings toward the operation of a PET
facility. Furthermore, this direct payment practice effectively eradicates the issue of
unpaid or underpaid bills from service providers, and achieves a solid accounting status
equivalent to 100% reimbursement.
By eliminating the reimbursement burden and the middle layer of insurance cost
with the direct payment culture, PET centers in Hong Kong are able to operate in a
more cost-effective and economically efficient way than their counterparts in Europe
and the United States.
Another prospect of a qualitative approach was to describe and interpret a
sudden phenomenal event of the influx of patients into Hong Kong.
Influx of patients. For many years, Hong Kong has been a medical center for
overseas Chinese because of its heritage link and high medical standards compared to
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the neighboring Southeast Asian countries (Hokari, 1996). Since the signing of the
Mainland and Hong Kong Closer Economic Partnership Arrangement (CEPA) in 2003,
people from China can travel to Hong Kong with fewer restrictions (2003). One of the
purposes of Mainland Chinese traveling to Hong Kong is to seek medical services
because they trust the ethical standards and the professionalism displayed by
healthcare professionals during the 2003 Severe Acute Respiratory Syndrome (SARS)
outbreak (Lee, 2003). Many patients are angry and tired of the unethical practices of
their healthcare providers in China, such as (i) ordering high cost but unnecessary
diagnostic services for a higher profit, (ii) prescribing overpriced medications for a
higher profit, and (iii) reports of physicians not giving patients the proper treatment, thus
causing unnecessary deaths and suffering (Ho, 1995).
In addition to the devotion and self-sacrifice of medical and healthcare staff
exhibited during the SARS outbreak (Lee, 2003), all 13 private hospitals in Hong Kong
are accredited either by the Trent Accreditation Board from the United Kingdom, or by
the Australia Council on Healthcare Standards (ACHS) from Australia (The Hong Kong
Private Hospitals Association, 2011). Some of these medical institutes are accredited
by both accreditation organizations. The Trent Accreditation Board is an assessment
scheme to support the development, integration, and assessment of organizational
standards in the United Kingdom for small to medium size hospitals (Trent Accreditation
Scheme, 2011).

The Australia Council on Healthcare Standards (ACHS) is Australia's

leading health care assessment and accreditation provider (ACHS, 2011). Due to the
history of 154 years of British colonial rule, Hong Kong private hospitals are trying to
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attach with those widely recognized standards within the developed commonwealth
countries to set themselves apart by providing an international standard of care.
Highly qualified and dedicated medical professionals combined with the state of
the art medical equipment and an international recognizable standard of care attracts
patients from Mainland China to seek medical services in Hong Kong.

Figure 6. Crude Birth Rate (CBR) and Crude Death Rate (CDR), 1981 – 2010.
Notes: The mortality and birth statistics are based on number of "registered" deaths and
births.
Source: Department of Health, The Government of Hong Kong SAR. (2010). Crude birth
rate (CBR) and crude death rate (CDR), 1981 – 2009. Retrieved from
http://www.chp.gov.hk/en/data/4/10/27/112.html
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The obvious example of this influx of patient from Mainland China is the reverse
trend of the birth rate in Hong Kong. According to the Hong Kong Department of
Health (2010), the birth rate has decreased from 16.8 per 1,000 population in 1981 to
7.1 in 2002, and leveled off in 2003. However, the birth rate has begun to show a
reverse trend since 2004, the first year CEPA became effective. It then reached a
significant height of 12.5 in 2010, a 76.1 % jump in just six years, and kept growing.
This birth rate figure indicates that approximately 50% of the newborn babies in
Hong Kong currently are coming from Mainland China. This unprecedented
phenomenon prompted the Hospital Authority of Hong Kong (the governing body of all
public hospitals in Hong Kong) to set up a separate admission procedure for pregnant
mothers from Mainland China in order to maintain an adequate maternity service for its
local citizens (Hospital Authority, 2010).
Another source of the patient influx is the expatriates from foreign companies.
Yang (2010) stated that between 1980 and 2007 China approved a total of 632,298
foreign-funded enterprises, and used US$766.655 billion in foreign investment. As the
global economy is shifting to the East, more and more foreign companies are either
setting up new offices or expanding their existing operations in China and Hong Kong.
When those expatriates seek medical services, they will go to Hong Kong simply
because they have confidence in physicians with U.S. government recognized
qualifications to practice in the specialties and those doctors are sufficiently competent
in the English language to provide services to English-speaking clients (US Consulate
Hong Kong, 2011). Hong Kong, given its geographic proximity to China, its bilingual
culture (English and Chinese), as well as a well-established pool of medical

42
professionals certified in the United States, is a natural and convenient hub to
accommodate an expatriate’s medical needs.
Although there are no official or direct statistics showing how many patients from
abroad are currently seeking PET services in Hong Kong, a personal survey from the
author showed that there was a range of 8% to 12% of patients who were non-Hong
Kong citizens (M. Yeung., personal communication, October 27, 2010; Anonymous,
personal communication, October 29, 2010). This tentative influx of patient
percentages translated into about 15 extra patients for the leading PET center as well
as about four extra patients for the average PET centers in Hong Kong in a week.

The Applicability of PET Utilization Experience to Developing Countries
After exploring the factors contributing to the PET utilization development in
Hong Kong, the author determined if those same factors were applicable to other
developing countries. As mentioned in previous paragraphs, the major factors
contributing to a higher ratio of PET-CT scanners in Hong Kong are:
1) medical expertise in a regionally profound disease
2) the direct payment culture which enables an economically efficient and a costeffective operation
3) the influx of patients from neighboring countries
4) the reputation of its medical services
As factors #1 and # 4 can be closely related and complementary to each other,
these two criteria will be discussed in a later section of this chapter. The applicability of
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factors #2 and #3 of PET utilization development experience in Hong Kong to other
developing countries will be illustrated first.
Factor #2 - The direct payment method. The direct payment method can be
readily applied to other developing countries if they wish to do so in order to boost an
economically efficient and a cost-effective operation. By eliminating the reimbursement
burden from the public social medical system, the private health management
organization, and the middle layer of insurance cost, PET centers are able to operate in
a more cost-effective and economically efficient way.
Factor #3 - An influx of paying patients. The goal is to create an influx of
paying patients to supplement the local medical demand.
As a matter of fact, the major hurdle in utilizing PET is the financial burden
associated with the costly equipment. According to Keppler and Conti (2001), the
average cost of setting up a PET center with the radiopharmaceutical production
capacity ranged from $5 million (low-cost scanner) to over $6.2 million (high-end
scanner) in the U.S. The running cost ranged from $1.6 million to over $2.6 million per
year. In order to make the service viable, the PET facility required a range from 3.45 to
6.75 procedures per day.
The advantage of the developing countries are their low property values and low
wages for physicians, nurses, and other healthcare providers such as Costa Rica, India,
Malaysia, Mexico, Philippines, Thailand, and similar countries. Those countries are
able to provide the same medical procedures at a much lower cost (Turner, 2010).
Table 6 shows the cost of performing a similar medical procedure in India ranges
from the lowest of 5.6% to highest of 21.2%, from 6.3% to 27.9% in Thailand, and from
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7.8% to 32.5% in Singapore, compared to the cost in the U.S. The average cost level
is about 13.4% for India (the mean of 5.6% and 21.2%), 17.1% for Thailand (the mean
of 6.3% and 27.9%), and 20.2% for Singapore (the mean of 7.8% and 32.5%) of the
cost in the U.S. (York, 2008).

Table 6
Comparative Costs of Medical Procedures by Country

Procedure

U.S.

India

Thailand

Singapore

Heart bypass

$130,000

$10,000

$11,000

$18,500

Heart valve
replacement

$160,000

$9,000

$10,000

$12,500

Angioplasty

$57,000

$11,000

$13,000

$13,000

Hip replacement

$43,000

$9,000

$12,000

$12,000

Knee
replacement

$40,000

$8,500

$10,000

$13,000

Source: ANA-OMSS Governing Council Report B June 2007--Appendix A. Adopted
from York, D. (2008). Medical tourism: The trend toward outsourcing medical
procedures to foreign countries. Journal of Continuing Education in the Health
Professions, 28(2), 99-102.

According to Gould (2008), there were an estimated 47 million individuals in the
U.S. who lacked health insurance. As proclaimed by York (2008), "In 2007, health care
spending was estimated at $2.2 trillion with the expectation that it will rise by 6.7%
through 2017, twice the rate of inflation" (p. 100). The rising cost of medical service in
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the US has fueled a movement of Americans traveling overseas for medical treatment
each year (York, 2008). The low-income and middle-class Americans with limited
finances are often unable to afford the cost of care in the U.S. They actually travel to
India, Thailand, or elsewhere for comparatively inexpensive health service (Gould,
2008). In Southeast Asia, the health sector is expanding rapidly, attributed to rapid
growth of the private sector in coping with medical tourism (Pocock & Phua, 2011).
A successful example is the Bumrungrad Hospital in Thailand. In 2006, after 60
Minutes aired its story about the hospital, Bumrungrad was bombarded with more than
3,000 emails from the U.S. from people interested in receiving treatment there. The
hospital claimed to provide care for more than 435,000 international patients every year;
58,000 of those patients were Americans (Turner, 2010). Bumrungrad Hospital is
famous for its (i) "rock-bottomed price" packages for medical surgery and other
procedures; (ii) the appearance and impression of a luxury hotel; and (iii) the philosophy
of promoting customer satisfaction. The Bumrungrad case demonstrated that given
enough incentives, price-conscious patients would travel in search of inexpensive health
care (Turner, 2010).
Medical facilities in developing countries can apply similar strategies of their low
property values, and low wages for physicians, nurses, and other healthcare providers
to attract price-conscious patients from overseas and create an influx of foreign patients
to help pay for the cost of their PET service.
Factor #4 - The buildup of reputation. Take the successful case mentioned
above in factor #3 of the Bumrungrad Hospital in Thailand as an example. It took
Bumrungrad Hospital about 10 years, from 1997 to 2006, to achieve an international
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recognition through a sound and consistent corporate philosophy combined with the
support of government policy (Turner, 2010). According to Pocock and Phua (2011),
Thailand's medical hub policy was begun in 2003 by the Thailand Board of Investment,
whilst the Ministries of Commerce and the Department of Export Promotion collaborated
with private hospitals.
In 2007 alone, Thailand provided medical services for as many as 1.4 million
foreign patients, including medical tourists, general tourists, and expatriates working or
living in Thailand or its neighboring countries (NaRanong & NaRanong, 2011).
Consequently, the buildup of a reputation is to attract an influx of paying patients who
can help pay for the advanced medical equipment and diagnostic methods otherwise
unaffordable and hence unavailable to its local citizens.
Factor #1 - Medical expertise in a regional profound disease. The purpose
of establishing a medical expertise in a regional profound disease is to build a
reputation, complementing the goal of attracting more fee paying foreign patients to
sustain the cost of advanced medical technology. This goal can be achieved in many
different ways.
First, if there is a regional profound disease readily presented in the developing
country in which the PET technology can be utilized to address this disease, then, this
country can directly apply the same PET development model in Hong Kong. It could
establish itself as an “X” disease center similar to the liver cancer center in Hong Kong.
Second, another approach that could be applied is to group a team of highly
trained medical professionals in one specialty area to launch a leading medical
expertise in the region. This is the case illustrated by the success of the Escorts Heart
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Institute and Research Center in Delhi and Faridabad of India. According to York
(2008), the Escorts Heart Institute “performs nearly 15,000 heart operations every year
and the death rate among patients during surgery is only 0.8 percent, less than half the
rate of most hospitals in the U.S.” (p. 100). This sheer volume of heart operations in
addition to the low cost of their surgeries, about one tenth of the cost compared to the
U.S., as shown in Table 4, put the Escorts Heart Institute in a position as one of the
leading heart centers in the world.
Third, take the successful case of the Bumrungrad Hospital in Thailand again as
an example. The Bumrungrad Hospital positioned itself as the hub of medical tourism.
Everyone can have a health assessment done as part of their touring plan to Thailand.
This model of a low cost health assessment center can basically be set up in any
country. As a matter of fact, governments in emerging markets such as Mexico,
Philippines, and Malaysia are promoting their medical tourist industry to attract medical
tourism (Pocock & Phua, 2011).
Based on the above demonstrations, all four factors of the PET development
experience in Hong Kong are applicable to other developing countries. The difference
is the time required to implement those policies. For factor #2 of the direct payment
method, the transition can be done in a short period of time to reach the level of cost
efficiency. For factors #1, #3 and #4, it may take up to 10 years to achieve the desired
effects of building up a medical expertise, attracting a significant amount of patient
influx, and establishing a reputation for medical tourism.
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CHAPTER 5
SUMMARY, CONCLUSIONS, RECOMMENDATIONS

Summary
The purpose of this research study was to (i) explore the factors contributing to
the PET utilization development in Hong Kong; and (ii) find out if those factors are
applicable to other developing countries.
Question 1. What is the clinical advantage of PET and PET-CT in the detection
and monitoring of cancer patients compared to conventional diagnostic imaging
modalities?
Question 2. How has the medical environment in Hong Kong affected PET
utilization development?
Question 3. How has the socioeconomic environment in Hong Kong affected
PET utilization development?

Research Question 1
To summarize the literature review of chapter 2 and compare to the findings in
chapter 4, the following is the evidence showing the clinical advantage of PET and PETCT in the detection and monitoring of cancer patients.
1. The principle of PET imaging technology is to detect the abnormal
accumulation of common nutrients, such as glucose, at the molecular level because the
metabolic rate of cancer cells is two to 10 times higher than that of normal cells
(Peterson et al., 2009). Those cancer cells will light up as hot spots compared to
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surrounding normal tissues on a 3-dimensional PET image, making them the easy
targets for disease identification.
2. For the evaluation of response to treatment, a PET scan can show the
effectiveness of surgery, chemotherapy, and radiotherapy in the treatment of cancer at
a much earlier time because it measures the metabolic activities of the cancer cells.
Cancer cells that are successfully treated will no longer be metabolically active but may
retain the same physical size for several months (Buck et al., 2010).
3. In the aid of radiotherapy planning, PET-based treatment planning showed a
significantly higher patient survival rate than those treated without the use of PET.
Therefore, 18F-FDG PET-CT is being incorporated into the treatment-planning process
and promises to improve the ability to confidently identify regions of disease (Buck et
al., 2010; Ford et al., 2009).
4. Extensive meta-analysis research by Gould et al. (2003), covering 23 CT and
32 PET studies; and Watson et al. (2007), covering patient data from 1994 to 2002; as
well as early studies by Bury et al. (1996) and Phelps (2000) further confirmed PET is
more sensitive and more specific than conventional diagnostic imaging for metastatic
disease and local recurrence of cancers respectively.
5. The emergence of PET-CT hybrid scanners in 2000 achieved high-resolution
anatomical images accurately co-registered with functional data, and this new
technology further increases the sensitivity and specificity of cancer imaging with PET
modality (Townsend, 2008).
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Based on the five major pieces of evidence stated above, it can be shown that
there is a clear clinical advantage of PET and PET-CT in the detection of cancer and
monitoring of cancer patients compared to conventional diagnostic imaging modalities.

Research Question 2
In order to answer the second research question, information was summarized
about the unique medical environment in Hong Kong affecting PET utilization
development.
Influenced by a locally profound cancer type, liver cancer, which is one of the top
three causes of cancer death in Hong Kong and many Asian countries, including China,
Taiwan, Singapore, and Japan (Ho et al., 2007), it is known that 18F-FDG PET has a 4050% false negative rate in the detection of liver cancer at that time (Chen et al., 2004;
Ho et al., 2003). In order to resolve this issue, the pioneer PET facility in Hong Kong
(HKSH) determined to tackle this weakness of liver cancer detection by PET. After
several years of extensive clinical trials (Chen et al., 2003; Chen et al., 2004; Chen et
al., 2006; Ho et al., 2003), a summary research result of the dual-tracer imaging
protocol of 11C-Acetate and 18F-FDG PET published by Ho et al. (2007) became a wellrecognized imaging protocol by the molecular imaging community worldwide. Indeed,
it was highlighted as the cover article for the 2007 issue of the Journal of Nuclear
Medicine. As the result of this proven protocol which eliminated a blind spot in the
cancer detection of PET, and with the collaboration with the largest liver cancer
treatment center in the region — The Department of Surgery at Hong Kong University,
as well as oncology specialists, HKSH is able to capture this clinical expertise and
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establish as well as promote itself with a medical reputation in a regionally profound
disease (liver cancer) and accommodate local patients as well as patients from abroad.
Encouraged by the proven clinical experience of PET and PET-CT in the detection and
monitoring of cancer patients compared to conventional diagnostic imaging modalities
both locally (HKSH) and overseas, private entities followed through and entered into the
field of PET imaging. Today, there are eight PET-CT scanners which are privately
owned out of the total of 12 PET-CT scanners in Hong Kong (Radiation Board,
Appendix A).
Therefore, the medical advancement of liver cancer treatment and detection
sped up the PET development in Hong Kong, which in turn answered the second
research question.

Research Question 3
To summarize the findings about the socioeconomic environment in Hong Kong,
which affect PET utilization development, the following are the key findings.
1. The direct payment culture means patients pay their medical expenses out of
their own pocket most of the time. By eliminating the reimbursement burden and the
middle layer of insurance cost, PET centers in Hong Kong are able to operate in a more
cost-effective and economically efficient way than their counterparts in Europe and the
United States.
2. There has been an influx of patients. For many years, Hong Kong has been a
medical center for overseas Chinese because of its heritage link and high medical
standards (Hokari, 1996). Since the signing of the Mainland and Hong Kong Closer
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Economic Partnership Arrangement in 2003, people from China can travel to Hong
Kong with fewer restrictions (CEPA, 2003).
One of the obvious examples of this influx is the reverse trend of birth rate in
Hong Kong. According to the Hong Kong Department of Health (2010), the birth rate
has decreased from 16.8 per 1,000 population in 1981 to 7.1 in 2002, but then
rebounded significantly to 12.5 in 2010. This birth rate figure indicates that
approximately 50% of the newborn babies in Hong Kong currently are coming from
Mainland China (Hospital Authority, 2010).
Another source of the patient influx is the expatriates from foreign companies.
According to Yang (2010), China approved a total of 632,298 foreign-funded enterprises
between 1980 and 2007. When those expatriates seek medical services, they will go
to Hong Kong simply because they have confidence in physicians with US government
recognized qualifications to practice in the specialties and those doctors are sufficiently
competent in the English language to provide services to English-speaking clients (US
Consulate Hong Kong, 2011).
Although there are no official or direct statistics showing how many Mainland
China patients and expatriates seek medical services in Hong Kong annually, given the
population of 1.3 billion in China (World Bank), and the example of the reversed birth
rate, a very small fraction of an influx from China will show a tremendous impact in the
medical system in Hong Kong.
Therefore, the third research question of the socioeconomic environment in Hong
Kong and its effect on PET utilization development is answered by two things: the
direct payment culture and the influx of patients. The direct payment culture enables
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the PET centers to operate in a more cost-effective and economically efficient way, and
the influx of patients from Mainland China and other overseas Chinese as well as
expatriates provides extra sources of financial support to the viability of PET facilities.

Summary of Findings
As mentioned in previous paragraphs, the key factors that have contributed to a
higher ratio of PET-CT scanners in Hong Kong are the following:
1) medical expertise in a regionally profound disease
2) the direct payment culture which enables an economically efficient and a costeffective operation
3) the influx of patients from neighboring countries
4) the reputation of its medical services
For factor #1 — establishing a medical expertise in a regionally profound
disease, the purpose of this is to build a reputation and can be achieved in at least two
ways.
First, if there is a regionally profound disease readily presented in the developing
country in which the PET technology can be utilized to address this disease, then this
country can directly apply the same PET utilization development model as Hong Kong.
That country could establish itself as an “X” disease center similar to the liver cancer
center in Hong Kong.
Second, another approach that can be applied is to become a leading medical
expertise in the region such as the successful case of the heart center of the Escorts
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Heart Institute and Research Center in Delhi and Faridabad of India, as mentioned in
Chapter 4.
For factor #2 — the direct payment method which enables a cost-effective
operation. The direct payment method can be readily applied to other developing
countries if those countries wish to do so in order to boost an economically efficient and
a cost-effective operation.
For factor #3 — the influx of patients from neighboring countries. The goal is to
create an influx of paying patients from other countries to supplement the local medical
demand.
For factor #4 — the buildup of a reputation of medical services. As factors #1
and # 4 can be closely related and complementary to each other, the main goal of
building up a reputation is the same, which is to attract an influx of paying patients who
can help pay for the advanced medical equipment and diagnostic methods otherwise
unaffordable and possibly unavailable to its local citizens.
Based on the above demonstrations, all four factors of the PET development
experience in Hong Kong are applicable to other developing countries. The difference
is the time required to implement those policies. For factor #2 of direct payment
method, the transition can be done in a short period of time to reach the level of cost
efficiency. Nevertheless, factors #1, #3 and #4 may take up to 10 years to achieve the
desired effects of building up a medical expertise, attracting a significant patient influx,
and establishing a reputation for medical tourism.
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Conclusions
According to the findings in Chapter 4, the cost figures in Table 6 (page 43) show
that the average cost level is about 13.4% for India (the arithmetic mean of 5.6% and
21.2%), 17.1% for Thailand (the arithmetic mean of 6.3% and 27.9%), and 20.2% for
Singapore (the arithmetic mean of 7.8% and 32.5%), compared to the cost in the U.S.
In a similar manner, the result from this study also showed that cost effectiveness is the
most significant factor which has enabled Hong Kong, a developing region with about
half the economic strength of Germany, to sustain a higher ratio of PET-CT scanners.
Buoyed by this direct payment culture which has the equivalence of 100%
reimbursement rate and the elimination of the entire middle layer of insurance cost,
billing coding hurdles, and reimbursement burden as well as bad debt, PET centers in
Hong Kong are able to operate in a more cost-effective and economically efficient way
than their counterparts in Europe and the United States. In addition, the reputation of a
medical expertise in a regionally profound disease—liver cancer, the influx of patients
from Mainland China, overseas Chinese as well as expatriates, and the international
accredited status of its medical services also play their complementary roles in
contributing to the higher ratio of PET technology.
In The World Is Flat, author Friedman (2005) suggested that most of us have no
idea of the breadth of economic globalization as it exists today. While people think of
globalization in terms of manufacturing and some segments of service industries, a
surprise movement in outsourcing is medical service.
Applying the same direct payment method, developing countries with a low cost
environment are able to set up and operate a PET facility with a much smaller overhead
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than their counterparts in the U.S. or Germany, making the latest medical technology
assessable to their citizens, which will have a noteworthy health benefit to their
countries.

Recommendations
Based on the findings of this study, the majority of PET service providers in Hong
Kong are from the private sector and they outnumber those in the public sector by a two
to one ratio. The following recommendations are offered in two directions. The first
set of recommendations is for the implementation of PET technology in developing
countries; and the second set of recommendations is for researchers who want to adopt
a quantitative approach to this topic in the future.

Recommendations for the Implementation of PET Technology in Developing
Countries
1. The implementation of advanced PET technology in developing countries
should be led by the private sector because private organizations are more efficient in
terms of maximizing the cost effectiveness and flexibilities in a competitive marketplace
compared to public organizations. This will increase the successful chance of
achieving a financially self-sustainable PET facility.
2. Contributions from both public resources and philanthropic foundations should
be sought to pay for the initial setup cost associated with a new PET facility because the
financial burden is the major hurdle preventing the utilization of this advanced
technology. Forms of contribution can include pieces of land, building materials,
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interior furnishings, medical equipment, direct monetary funding, etc. This will greatly
reduce the debt level and improve the viability of the new facility.

Recommendations for Researchers
Private PET centers in Hong Kong are more or less competitors among themselves in
the market of medical services. Sensitive patient and operational data such as patient
demographics which will enable a quantitative analysis to study the financial impact of
the influx of patients are guarded as business secrets. The following recommendations
are offered to researchers who want to adopt a quantitative approach to this topic in the
future.

1. Spend more time convincing the practitioners of these private PET facilities
that the confidentiality of their patient and operational data will be maintained.
2. Ask permission to collect patient data on site without the expenses of
additional resources from these private facilities.
3. Seek approval from the public hospitals to conduct patient data survey to
complete the whole picture of PET Services in Hong Kong.
4. Keep in mind the sensitivity and the feelings of patients and their relatives
while collecting demographic data because cancer is a devastating disease to
most of the people.
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Appendix A
Radiation Board Correspondences

Email dated October 16, 2011.

Dear Steve,
Thank you very much for your message dated 11 Oct 2011 below.
I would like to provide the information as follows:
1.
How many PET scanners are operational in Hong Kong in year 2011? According
to our licensing records, there are currently 11 PET scanners in HK.
2.
How many of those PET scanners are from private sector? 8 of them are from
private sector.
3.
When was the established year of operation of the first three PET centers in Hong
Kong? The first 3 PET centres were established in 1998, 2001 and 2003.
4.
When was the established year of operation of the first PET center in public
hospital (QMH)?2003 (QEH)
Thank you very much for your attention.
Best regards
Joseph Mok
Radiation Board
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Email dated October 18, 2011.

Dear Steve,
Yes, we have not include the PYNEH as the centre is not commenced operation.
For Q3, your sequence is correct but I have to correct that the year should be 1998,
2001, 2002.
Thank you very much for your attention.
Best regards
Joseph

Steve Sitt <stevesitt@siu.edu>
17/10/2011 23:53

To:
p3_rhu@dh.gov.hk
cc:
Subject:
Re: Fw: PET Survey Request

Good morning Joseph,
What a pleasant surprise to receive a response from you! Thank you very much for your
detailed information. Please thank Dr. Cheng for giving permission to use these data
and let you, one of the most experienced and resourceful persons from the Radiation
Board of the Department of Health in Hong Kong, handle this case.
For question #1, apart from the existing operations, there were two private PET centers
ran out of business during the last few years, one located in Causeway Bay (Hercules)
and another in Central. Those business events made the number of total scanners
fluctuate in the last 10 years. Therefore, these data needs to be updated often.
The following demographic data shows a total of 12 PET scanners because I counted
the one under installation at PYNEH. Is this the source of our total number discrepancy?
Please advice.
NT:
PWH 1 PET-CT
Union 1 PET-CT

Kowloon:
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Baptist 1 PET-CT
St Teresa 1 PET-CT
Evangel 1 PET-CT
QEH 1 PET-CT
油麻地 1PET-CT (HK Healthcheck Company Limited)
HK:
HKSH 2 PET-CT
Adventist 1 PET-CT
QMH 1 PET-CT
PYNEH 1 PET-CT (under installation)
For question #3, the order of the 1st, 2nd,and 3rd PET center is HKSH, St Teresa and
HK Adventist. Pleaseconfirm the validity of my sequence.
Thank you very much for your attention and have a good day.
Steve
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Appendix B
Medical Claim Forms from Major Insurance Providers in Hong Kong
(In alphabetical order)

American International Assurance Company (Bermuda) Limited
Bank of China Group Insurance Company Limited
Bupa
CIGNA Worldwide Life Insurance Company Limited
HSBC Insurance
Hong Leong Insurance (Asia) Ltd.
ING General Insurance International
Manulife Individual Insurance
Sompo Japan Insurance (Hong Kong) Co., Ltd.
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American International Assurance Company (Bermuda) Limited

74

75
Bank of China Group Insurance Company Limited

76
Bupa

77

78
CIGNA Worldwide Life Insurance Company Limited

79

80
HSBC Insurance

81

82
Hong Leong Insurance (Asia) Ltd.

83

84
ING General Insurance International

85

86
Manulife Individual Insurance

87

88
Sompo Japan Insurance (Hong Kong) Co., Ltd.

89

90
VITA

Graduate School
Southern Illinois University

Steve Sitt
stevesitt@siu.edu
stevesitt@gmail.com (permanent email address after graduation)

The Chinese University of Hong Kong, Hong Kong
Bachelor of Arts, Philosophy, May 1988
The Johns Hopkins Hospital, Baltimore, Maryland
Certificate, Nuclear Medicine Technology, 1993

Thesis Title:
Positron Emission Tomography Utilization Development in Hong Kong

Major Professor: Barbara Hagler, Ph.D.

